Intended for healthcare professionals

  1. News & Views
  2. The idolatry of the...
  3. The idolatry of the surrogate
Analysis

The idolatry of the surrogate

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7995 (Published 28 December 2011) Cite this as: BMJ 2011;343:d7995

Related articles

See more

Cited by...

  • Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials
  • Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis
  • Raising the bar for using surrogate endpoints in drug regulation and health technology assessment
  • Aducanumab for Alzheimers disease - too many unanswered questions
  • A scholarship to foster future leaders in evidence based medicine
  • Patient and Caregiver Priorities for Outcomes in Peritoneal Dialysis: Multinational Nominal Group Technique Study
  • Cardiovascular Outcomes Reported in Hemodialysis Trials
  • Clinicians and researchers perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study
  • Considerations and Challenges in Selecting Patient-Reported Outcome Measures for Clinical Trials in Nephrology
  • Evidence based medicine manifesto for better healthcare: A response to systematic bias, wastage, error and fraud in research underpinning patient care
  • Users guide to the surgical literature: how to assess an article using surrogate end points
  • Are outcomes reported in surgical randomized trials patient-important? A systematic review and meta-analysis
  • Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990-2011
  • Nephrologists Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis
  • A Meta-Analysis of Peer-Support Interventions for Adults With Diabetes
  • Les lignes directrices en soins primaires devraient-elles etre redigees par des medecins de famille?: OUI
  • Should primary care guidelines be written by family physicians?: YES
  • Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence
  • Guidelines for treating risk factors should include tools for shared decision making
  • Excessive testing of adults with type 2 diabetes
  • Ten Commandments for patient-centred treatment
  • Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study
  • How medicine is broken, and how we can fix it
  • The epidemic of pre-diabetes: the medicine and the politics
  • Just stick to the facts: remember Goodharts law
  • Guidelines: is bigger better? A review of SIGN guidelines
  • Towards evidence based medicine for paediatricians
  • Where is the evidence based on hard endpoints for the safety and effectiveness of sitagliptin in type 2 diabetes?
  • 'Hard,' 'soft' and 'surrogate' endpoints in diabetes
  • Using 'amenable mortality' as indicator of healthcare effectiveness in international comparisons: results of a validation study
  • Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study
  • Recommendations on screening for cervical cancer
  • Tocolytics: do they actually work?
  • The 11th hour-time for EBM to return to first principles?
  • Reducing the Cardiovascular Disease Burden: Justified Means for Getting to the End
  • What matters most to patients?
  • Brave new post-iconoclastic world
  • Type 2 diabetes is a poor example of the overuse of surrogate markers
  • Surrogate end points: studying their benefits, taxonomy, and semantics
  • Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes
Back to top